Business
PAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary
PAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary.
About this update from Pao Group, Inc.
[{"type":"text","content":"\n\n\n\nPAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation Subsidiary\nPR Newswire\nSANDUSKY, Ohio, Feb. 3, 2021\n\n\n\nSANDUSKY, Ohio, Feb. 3, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced the company anticipates reporting an estimated $50,000 in revenue for Q4 2020.\nThe revenue is anticipated from a $300,000 sales agreement executed by PAOG's cannabis cultivation subsidiary.\nLast summer, PAOG acquired a cannabis cultivation business from Puration, Inc. (USOTC: PURA). The acquisition was made in conjunction with PAOG's overall strategy to refresh and renew its overall cannabis healthcare industry strategy.\nLast year, also in conjunction PAOG's plan to refresh and renew its overall cannabis healthcare industry strategy, the company with PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a cannabis treatment under development for Chronic Obstructive Pulmonary Disorder (COPD) derived from a patented cannabis extraction method - U.S. Patent No. 9,199,960 entitled \"METHOD AND APPARATUS FOR PROCESSING HERBACEOUS PLANT MATERIALS INCLUDING THE CANNABIS PLANT.\"\nAs part of the transaction with PURA, PAOG plans to issue a dividend of one share to PURA shareholders for every one share held of PURA stock. PAOG and PURA anticipate announcing dividend details soon pending the completion of necessary approvals now underway.\nPAOG anticipates approximately $50,000 in revenue per quarter for the next six quarters from the aforementioned $300,000 sales agreement.\nLearn more about PAOG at www.paogroupinc.com.\nForward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including,...